S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65

Novita Healthcare Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume8.20 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive NHL News and Ratings via Email

Sign-up to receive the latest news and ratings for Novita Healthcare and its competitors with MarketBeat's FREE daily newsletter.

About Novita Healthcare

Novita Healthcare Limited engages in the development and commercialization of healthcare technologies in Australia. The company operates through Research and Development, Healthcare/Workforce Management, and Investments segments. It offers TALI Train, a game-based training program to treat and monitor cognitive problems, such as attention difficulties in early childhood. The company also develops a technology solution for care or support professionals looking for employment, as well as for aged care or disability support providers needing staff. In addition, it primarily invests in Australian equities. The company was formerly known as Avexa Limited and changed its name to Novita Healthcare Limited in December 2016. Novita Healthcare Limited was founded in 2004 and is based in Glen Iris, Australia.


See More Headlines

Industry, Sector and Symbol

Health Information Services
Year Founded

Sales & Book Value

Annual Sales





Next Earnings Date
Not Optionable


Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Novita Healthcare (ASX:NHL) Frequently Asked Questions

What stocks does MarketBeat like better than Novita Healthcare?

Wall Street analysts have given Novita Healthcare a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novita Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Novita Healthcare's earnings last quarter?

Novita Healthcare Ltd (ASX:NHL) issued its quarterly earnings results on Tuesday, February, 26th. The company reported $0.00 earnings per share (EPS) for the quarter.
View Novita Healthcare's earnings history

Who are Novita Healthcare's key executives?

Novita Healthcare's management team includes the following people:
  • Ms. Magda Klapakis, Head of Fin. & Financial Controller
  • Dr. Hannah Kirk, Chief Research Officer
  • Mr. Glenn Smith, COO & MD
  • Mr. Stephen Denaro BCom, GradDipApp CG, CA, MAICD, Company Sec.

What is Novita Healthcare's stock symbol?

Novita Healthcare trades on the ASX under the ticker symbol "NHL."

How much money does Novita Healthcare make?

Novita Healthcare has a market capitalization of $0.00.

How many employees does Novita Healthcare have?

Novita Healthcare employs 13 workers across the globe.

What is Novita Healthcare's official website?

The official website for Novita Healthcare is www.novitahealthcare.com.au.

How can I contact Novita Healthcare?

The company can be reached via phone at 61 3 9192 9937.

This page was last updated on 10/19/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.